1. Introduction {#s1}
===============

China is facing a rapidly increasing aging population like many other developing countries, and it is estimated that almost 150 million Chinese will be over 75 years of age by 2050.[@b1] The incidence of ischemic heart disease (IHD) and percutaneous coronary intervention (PCI) are also consistently growing. In fact, patients ≥ 75 accounted for about 40% of the deaths caused by IHD.[@b2] Furthermore, age has been reported closely related to higher mortality and incidence of complications after PCI.[@b3],[@b4] Although age alone is not a contraindication to PCI, there is a lack of evidence regarding the optimal management of elderly patients undergoing PCI, especially in Chinese patients. Thus, there is a need to evaluate the safety and effectiveness of PCI in the specific patient group. The purpose of this research was to investigate clinical and angiographic characteristics of elderly patients who underwent PCI and assess risk factors related to post-PCI deaths and complications in patients ≥ 75 years of age.

2. Methods {#s2}
==========

2.1. Data sources and inclusion criteria {#s2a}
----------------------------------------

We retrospectively scanned 2,522 consecutive coronary heart disease patients admitted to the Cardiology Department of Shanghai Changzheng Hospital between December 2011 and November 2013, according to the criteria recommended by the 2013 ESC and ACCF/ASA guidelines.[@b5]--[@b7] Data were collected through clinical and PCI records, including demographic characteristics, PCI procedure details, medical history, and in-hospital complications. The followed-up was to gain the data on mortality and complications at six months. 573 patients who didn\'t undergo intervention process (patients\' rejection, adopting other medical therapy, or transfer, etc.), 885 patients with digital subtraction angiography (DSA), and 30 patients whose in-hospital data and follow-up information were missing were excluded. 1,035 patients were finally included in this research. The patients aged between 30 and 92 years (64 ± 11 years). Among them, 213 patients were ≥ 75 (20.6%). The following cardiovascular risk factors were evaluated: hypertension, diabetes mellitus, chronic kidney failure, chronic obstructive pulmonary disease, peripheral vascular disease (PAD), dyslipidemia, stroke history, prior myocardial infarction, prior revascularization \[PCI or coronary artery bypass grafting (CABG)\], smoking, as well as in-hospital conditions including arrhythmia, cardiogenic shock. We also assessed the diagnosis of disease precisely, such as in-hospital biochemical biomarkers, and angiographic results of angioplasty.

2.2. Definitions {#s2b}
----------------

Emergency PCI was defined as PCI operated within 6 h after onset of ischemic symptoms of the heart. Diabetes included both type I and type II diabetics. Hypertension was defined as systolic blood pressure ≥ 140 mmHg, diastolic blood pressure ≥ 90 mmHg, or antihypertensive therapy at admission. Chronic kidney disease (CKD) was defined as abnormalities of kidney structure or function (imaging examination or biochemical examination), present for ≥ 3 months or a glomerular filtration rate \< 60 mL/min per 1.73 m^2^ based on patients\' medical history or renal replacement therapy at admission. Cardiogenic shock at admission was defined as systolic blood pressure \< 90 mmHg or Killip IV grade at admission. Severe arrhythmia included ventricular fibrillation/flutter, atrial fibrillation/flutter, supraventricular tachycardia (SVT), ventricular tachycardia (VT), high-grade A-V block, bradycardia with heart rate \< 45 beats/min. In-hospital outcomes included death, contrast-induced nephropathy, hemorrhagic complications and arrhythmia complications. Six-month outcomes included death, nonfatal myocardial infarction, revascularization including target vessel revascularization (TVR) and target lesion revascularization (TLR), as well as the composite outcome of major adverse cardiovascular event (MACE), which was defined as being any of the above individual outcomes.

2.3. Statistical analyses {#s2c}
-------------------------

All data were analyzed using SPSS 18.0. Binary data were presented by percentage, while qualitative data were presented as mean ± SD. Comparison of the two groups was performed using a chi-square test. Univariable and multivariable logistic regression were used in analyzing risk factors related to outcomes of PCI in patients ≥ 75. Risk factor correlations were considered significant in multivariable logistic regression if *P* \< 0.10, and were considered significant in univariable logistic regression if *P* \< 0.05.

3. Results {#s3}
==========

3.1. Baseline demographic characteristics {#s3a}
-----------------------------------------

The baseline demographic characteristics of the research population are given in [Table 1](#jgc-12-06-626-t01){ref-type="table"}. The whole population was divided into four categories: (1) patients with SA ≥ 75 years (*n* = 58, 5.6%); (2) patients with SA \< 75 years (*n* = 218, 21.0%); (3) patients with acute coronary syndrome (ACS) ≥ 75 years (*n* = 155, 15.0%); (4) patients with ACS \< 75 years (*n* = 604, 58.4%). The male gender was predominant in all groups, and smoking was more prevalence in the younger patients. For ACS patients, there was a higher prevalence of hypertension (74.8% *vs*. 65.1%, *P* \< 0.05), CKD (7.1% *vs*. 3.5%, *P* \< 0.05), chronic obstructive pulmonary disease (COPD) (7.1% *vs*. 2.3%, *P* \< 0.01), and PAD (11.0% *vs*. 6.1%, *P* \< 0.05) in the elderly group. History of stroke, prior revascularization (PCI or CABG), cardiogenic shock and severe arrhythmia at admission were also more common in the elderly group. However, only hypertension, COPD and prior stroke showed a difference between patients ≥ 75 years old and \< 75 years old with SA.

3.2. Biochemical variables at admission {#s3b}
---------------------------------------

Biochemical variables at admission are shown in [Table 2](#jgc-12-06-626-t02){ref-type="table"}. Admission conditions were worse in patients ≥ 75 years with ACS. Compared with patients \< 75 years, the elderly had lower hemoglobin (121.059 ± 28.70 g/L *vs*. 137.32 ± 28.70 g/L *P* \< 0.01), platelet counts and albumin, higher creatinine, uric acid, urea nitrogen and pro-BNP (1750.49 ± 2222.81 pg/mL *vs*. 756.33 ± 1400.55 pg/mL, *P* \< 0.01). However, blood lipids were better in the elderly group with relative lower triglyceride (1.35 ± 0.70 mmol/L *vs*. 1.72 ± 1.14 mmol/L *P* \< 0.01) and higher high density lipoprotein (HDL) (1.06 ± 0.33 mmol/L *vs*. 0.97 ± 0.35 mmol/L *P* \< 0.05). Same results could be seen among SA patients with lower plasma cholesterol (3.73 ± 0.77 mmol/L *vs*. 4.10 ± 1.00 mmol/L *P* \< 0.05), triglyceride (1.37 ± 0.76 *vs.* 1.86 ± 1.20 mmol/L *P* \< 0.01) and low density lipoprotein (LDL) (2.21 ± 0.68 mmol/L *vs*. 2.50 ± 0.8 mmol/L, *P* \< 0.05).

###### Baseline demographic characteristics of the population.

                                               ACS                         SA                                    
  --------------------------------------- -------------- -------------- --------- -------------- --------------- ---------
  Age (yrs)                                79.24 ± 3.51   59.81 ± 8.76   \< 0.01   78.72 ± 2.72   61.83 ± 7.55    \< 0.01
  Weight (Kg)                              61.94 ± 8.20   69.3 ± 10.27   \< 0.01   66.69 ± 9.59   69.76 ± 12.07   \< 0.05
  Female                                    62 (40.0%)    113 (18.7%)    \< 0.01    17 (29.3%)     55 (25.2%)      0.318
  Smoking                                   34 (21.9%)    338 (56.0%)    \< 0.01    15 (25.9%)     91 (41.7%)     \< 0.05
  Comorbidities                                                                                                  
  Hypertension                             116 (74.8%)    393 (65.1%)    \< 0.05    49 (84.5%)     148 (67.9%)    \< 0.01
  Diabetes mellitus                         40 (25.8%)    131 (21.7%)     0.282     15 (25.9%)     72 (33.0%)      0.342
  Chronic kidney disease                    11 (7.1%)      21 (3.5%)     \< 0.05     1 (1.7%)       4 (1.8%)       0.955
  Chronic obstructive pulmonary disease     11 (7.1%)      14 (2.3%)     \< 0.01    6 (10.3%)       5 (2.3%)      \< 0.05
  Peripheral vascular disease               17 (11.0%)     37 (6.1%)     \< 0.05    10 (17.2%)      21 (9.6%)      0.103
  Dyslipidemia                              10 (6.5%)      63 (10.4%)     0.134      4 (6.9%)       21 (9.6%)      0.519
  Related medical history                                                                                        
  Prior myocardial infarction                6 (3.9%)      44 (7.3%)      0.126      5 (8.6%)      32 (14.7%)      0.229
  Prior Stroke                              25 (16.1%)     45 (7.5%)     \< 0.01    14 (24.1%)      14 (6.4%)     \< 0.01
  Prior PCI/CABG                             5 (3.2%)      48 (7.9%)     \< 0.05     5 (8.6%)      27 (12.4%)      0.426
  Cardiogenic shock at admission            26 (16.8%)     28 (4.6%)     \< 0.01     2 (3.4%)       5 (2.3%)       0.982
  Severe arrhythmia at admission            33 (21.3%)     59 (9.8%)     \< 0.01    9 (15.5%)       17 (7.8%)      0.074

ACS: acute coronary syndrome; CABG: coronary artery bypass grafting; MACE: major adverse cardiovascular event; PCI: percutaneous coronary intervention; SA: stable angina.

###### Biochemical variables at admission and surgical data of the population.

                                        ACS                               SA                                           
  ----------------------------- ------------------- ------------------ --------- ------------------ ------------------ ---------
  Hemoglobin (g/L)                121.059 ± 28.70     137.32 ± 28.70    \< 0.01    128.53 ± 27.13     137.67 ± 22.47    \< 0.01
  Platelet (×10^9^/L)             180.03 ± 57.37      210.64 ± 71.15    \< 0.01    190.70 ± 55.27     198.88 ± 59.04     0.344
  Blood glucose (mmol/L)            6.93 ± 2.79        6.79 ± 2.94       0.603      6.04 ± 1.97        6.24 ± 2.43       0.646
  Plasma cholesterol (mmol/L)       3.91 ± 0.96        3.96 ± 1.02       0.535      3.73 ± 0.77        4.10 ± 1.00      \< 0.05
  Triglyceride (mmol/L)             1.35 ± 0.70        1.72 ± 1.14      \< 0.01     1.37 ± 0.76        1.86 ± 1.20      \< 0.01
  HDL (mmol/L)                      1.06 ± 0.33        0.97 ± 0.35      \< 0.05     1.04 ± 0.27        1.02 ± 0.36       0.704
  LDL (mmol/L)                      2.44 ± 0.77        2.45 ± 0.81       0.88       2.21 ± 0.68        2.50 ± 0.87      \< 0.05
  Albumin (g/L)                    38.65 ± 7.72        41.28 ± 5.94     \< 0.01     41.95 ± 5.07       42.20 ± 4.53      0.716
  ALT\* (U/L)                     52.37 ± 199.47      38.78 ± 32.38      0.408     26.62 ± 19.24      27.05 ± 16.40      0.864
  AST\* (U/L)                     94.04 ± 146.59      66.68 ± 112.15    \< 0.05    33.84 ± 27.64      25.56 ± 14.99     \< 0.05
  Bilirubin\* (μmol/L)             13.99 ± 7.10        14.24 ± 6.45      0.698      13.81 ± 8.75       13.69 ± 8.88      0.928
  LDH\* (U/L)                    636.76 ± 1182.63    471.56 ± 520.44     0.174     204.08 ± 66.94    249.69 ± 168.84    \< 0.05
  Creatinine (μmol/L)              86.34 ± 33.74      75.48 ± 35.63     \< 0.01    83.95 ± 21.18      77.03 ± 43.78      0.244
  Uric acid (μmol/L)              350.36 ± 120.22    327.99 ± 118.83    \< 0.05    355.17 ± 90.06    332.99 ± 117.21     0.204
  Urea nitrogen^a^                  6.82 ± 2.74        5.84 ± 3.09      \< 0.01     6.19 ± 2.12        6.03 ± 1.88       0.586
  CK^\#^ (U/L)                   686.74 ± 1239.19    640.75 ± 1265.52    0.704     103.78 ± 73.33     94.62 ± 82.36-     0.494
  CK-MB^\#^ (U/L)                 72.01 ± 125.48      70.55 ± 141.08     0.910     18.93 ± 10.21       16.93 ± 9.29      0.203
  Elevation of TnT^\#^              70 (47.3%)         234 (41.9%)       0.235        3 (6.1%)          15 (7.7%)        0.951
  Pro-BNP^\#^ (pg/mL)            1750.49 ± 2222.81   756.33 ± 1400.55   \< 0.01   731.80 ± 1081.07   516.33 ± 1193.67    0.384
  SBP (mmHg)                      129.34 ± 22.37      128.52 ± 19.97     0.679     137.57 ± 21.77     130.30 ± 16.71    \< 0.05
  DBP (mmHg)                       75.80 ± 12.48      79.79 ± 12.22     \< 0.01     76.55 ± 9.01      79.12 ± 12.58      0.146

\*Data missing for 1.5% (16) of the population. \#Data missing for 13% (136) of the population. ACS: acute coronary syndrome; ALT: alanine aminotransferase; AST: aspartate aminotransferase; CK: creatine kinase; CK-MB: creatine kinase isoenzyme-MB; DBP: diastolic blood pressure; HDL: high density lipoprotein; LDH: lactate dehydrogenase; LDL: low density lipoprotein; pro-BNP: pro-brain natriuretic peptide; SA: stable angina; SBP: systolic blood; TnT: troponin T.

###### Angiographic and procedural characteristics.

                                 ACS                       SA                                 
  ------------------------- ------------- ------------- --------- ------------- ------------- -------
  Emergency PCI              48 (31.0%)    141 (23.3%)    0.050        \-            \-         \-
  Radial approach            110 (71.0%)   506 (83.8%)   \< 0.01   46 (79.3%)    189 (86.7%)   0.160
  Drug-eluting stent u-se    148 (95.5%)   582 (96.4%)    0.471    55 (94.8%)    213 (97.7%)   0.613
  Stent implantation                                                                          
  Diseased vessels                                                                            
  LAD                        149 (96.1%)   555 (91.9%)    0.069    249 (90.2%)   196 (89.9%)   0.738
  LCX                        105 (67.7%)   356 (58.9%)   \< 0.05   37 (63.8%)    141 (64.7%)   0.900
  RCA                        119 (76.8%)   398 (65.9%)   \< 0.05   177 (64.1%)   141 (64.7%)   0.713
  Multi-vessel disease       132 (85.2%)   446 (73.8%)   \< 0.01   44 (75.9%)    162 (74.3%)   0.193
  Double vessel              42 (27.1%)    184 (30.5%)             24 (41.4%)    64 (29.4%)   
  Triple vessel              90 (58.1%)    262 (43.4%)             20 (34.5%)    98 (45.0%)   
  Left main lesion            14 (9.0%)     36 (6.0%)     0.169         0         11 (5.0%)    0.171
  Chronic total occlusion    20 (12.9%)     36 (6.0%)    \< 0.01    1 (1.7%)      13 (6.0%)    0.332
  Myocardial bridge           9 (5.8%)      56 (9.3%)     0.169     6 (10.3%)     15 (6.9%)    0.545
  Calcified lesion           42 (27.1%)    96 (15.9%)    \< 0.01   15 (25.9%)    45 (20.7%)    0.401
  IABP use                    6 (3.9%)      7 (1.2%)     \< 0.05       \-            \-         \-

ACS: acute coronary syndrome; CTO: chronic total occlusion; IABP: intra-aortic balloon pump; LAD: left anterior descending coronary artery; LCX: left circumflex coronary artery; PCI: percutaneous coronary intervention; RCA: right coronary artery; SA: stable angina.

3.3. Procedure characteristics {#s3c}
------------------------------

Coronary disease was more severe in the elderly that presented with ACS, with multi-vessel disease (85.2% *vs*. 73.8% *P* \< 0.01) and significantly more frequent in left circumflex artery (LCX) and Right coronary artery (RCA) lesions, calcified lesions and chronic total occlusion (12.9% *vs*. 6.0%, *P* \< 0.01) than younger patients. However, these differences weren\'t seen in SA patients. Furthermore, Intra-aortic balloon pump (IABP) was more frequently used in the elderly group (3.9% *vs*. 1.2%, *P* \< 0.05). Procedure characteristics are shown in [Table 3](#jgc-12-06-626-t03){ref-type="table"}.

3.4. Clinical outcomes {#s3d}
----------------------

In-hospital and six-month follow-up were completed for all 1,035 patients. In-hospital mortality was 3.3% in patient ≥ 75 years and 1.0% in the younger group and all deaths of patients ≥ 75 years occurred in ACS patients. Overall mortality at six months was 6.1% in the elderly group and 1.9% in patients \< 75 years. Hemorrhagic complications and contrast nephropathy were more common in the elderly patients with ACS, compared with younger patients. However, there was no difference between the two age groups in nonfatal myocardial infarction, revascularization and MACEs at six months, regardless of ACS or SA. Kaplan Meier analysis of cumulative survival ([Figure 1](#jgc-12-06-626-g001){ref-type="fig"}) and event-free survival (death, myocardial infarction and revascularization, [Figure 2](#jgc-12-06-626-g002){ref-type="fig"}) demonstrated significant differences in survival among the four groups. Univariable analysis OR determined that age ≥ 85 years (OR = 5.155, *P* = 0.024), emergency PCI (OR = 7.385, *P* = 0.006), chronic kidney failure (OR = 8.444, *P* = 0.02), cardiogenic shock at admission (*P* \< 0.001), severe arrhythmia at admission (*P* \< 0.001), prior stroke (OR = 5.219, *P* = 0.015) were all associated with a higher mortality rate at six months in elderly patients ≥ 75 years old who underwent PCI ([Table 4](#jgc-12-06-626-t04){ref-type="table"}). Multivariate logistic analysis identified chronic kidney failure, cardiogenic shock at admission, severe arrhythmia at admission and prior stroke as independent predictors of six-month mortality.

4. Discussion {#s4}
=============

This single center retrospective study was conducted with a cohort of 1,035 patients who underwent PCI, with 213 patients ≥ 75 years. Our study showed that over 20% patients undergoing PCI are elderly patients ≥ 75 years old, consistent with a recent study conducted among patients with acute myocardial infarction.[@b8] In fact, the proportion of elderly patients ≥ 75 years who underwent nonemergency PCI had increased from 8.7% in 2000 to 13.7% in 2007, according to the research by the Scottish Coronary Revascularization Register.[@b9] Additionally, another register suggested that PCI for ST-segment elevated myocardial infarction among patients ≥ 80 years reached 31.2% in 2010, compared to 9.2% in 2001.[@b10] Elderly patients have gradually become a more important category of patients in the PCI practice.

###### In-hospital and six-month outcomes of PCI.

                                                                 ACS           *P*         SA        *P*                  
  ---------------------------------------------------------- ------------ ------------- --------- ---------- ------------ -------
  In-hospital events                                                                                                      
   In-hospital deaths                                          7 (4.5%)     6 (1.0%)     \< 0.01      0        2 (0.9%)    1.00
   Hemorrhagic complications                                  14 (9.0%)     26 (4.3%)    \< 0.05   4 (6.9%)    8 (3.7%)    0.478
   Hematoma, pseudoaneurysm or other vascular complication        12           24                     4           8       
   Retroperitoneal hematoma                                       1             2                     0           0       
   Coronary artery perforation                                    1             0                     0           0       
   Acute stent thrombosis                                      2 (1.3%)     6 (1.0%)      1.00        \-          \-        \-
   Arrhythmia complications                                    5 (3.2%)     11 (1.8%)     0.44     2 (0.7%)       0        1.00
   Contrast nephropathy                                        7 (4.5%)     3 (0.5%)     \< 0.01   1 (1.7%)    1 (0.5%)    0.377
  Six-month events                                                                                                        
   Six-month deaths                                           13 (8.4%)     14 (2.3%)    \< 0.01      0        2 (0.9%)    1.00
   Cardiac death                                              12 (7.7%)     11 (1.8%)                 0        2 (0.9%)   
   Others                                                      1 (0.6%)     3 (0.5%)                  0           0       
   Myocardial infarction                                       5 (3.2%)     6 (1.0%)      0.090    2 (3.4%)    2 (0.9%)    0.196
   Revascularization                                          21 (13.5%)   91 (15.1%)     0.635    5 (8.6%)   23 (10.6%)   0.665
   MACEs                                                      31 (20.0%)   102 (16.9%)    0.363    4 (6.9%)   27 (12.4%)   0.239

ACS: acute coronary syndrome; MACE: major adverse cardiovascular event; SA: stable angina.

![Kaplan-Meier survival curve of cumulative survival at six months for whole study population.\
ACS: acute coronary syndrome.](jgc-12-06-626-g001){#jgc-12-06-626-g001}

![Kaplan-Meier survival curve of event-free (death, myocardial infarction and revascularization) survival for whole study population.\
ACS: acute coronary syndrome.](jgc-12-06-626-g002){#jgc-12-06-626-g002}

###### Effects of multiple variables on six-month mortality in univariate and multivariate logistic regression analysis.

                                    Univariate analysis   Multivariate analysis                                     
  -------------------------------- --------------------- ----------------------- ---------- -------- -------------- -------
  Age ≥ 85 yrs                             5.155              1.238−21.459         0.024                            
  Cardiogenic shock at admission          11.933              3.760−37.876        \< 0.001   5.819    1.471−23.015   0.012
  Severe arrhythmia at admission           9.055              2.852−28.747        \< 0.001   11.275   2.503−50.778   0.002
  Chronic kidney failure                   8.444              2.214−32.201          0.02     9.038    1.271−64.247   0.028
  Previous stroke                          5.219              1.713−15.896         0.015     5.222    1.262−21.603   0.023
  Emergency PCI                            7.385              2.343−23.273         0.001                            

PCI: percutaneous coronary intervention.

In the last decade, it had been proven by a series of studies,[@b11]--[@b13] that performing PCI on elderly patients ≥ 75 years may not yield as much risk as had been previously imagined, in spite of the fact that nearly all of these studies focused exclusively on patients with acute myocardial infarction. Our study also confirmed PCI as a relatively safe strategy for coronary heart disease management among patients ≥ 75 years with acceptable in-hospital mortality (3.3%) and six-month mortality (6.1%). However, there still exists some hesitation among cardiologists in using PCI as treatment for myocardial infarction among patients ≥ 75 years, due to the concern of a high rate of complications, relatively unfavorable outcomes, and a high prevalence of complex comorbidities.[@b14]

In this study, we have included patients with coronary heart disease presenting as SA---an under researched group by previous studies. Our data suggested a significant difference of clinical and perioperative characteristics between patients ≥ 75 years and patients \< 75 years, with elderly patients having more comorbidities and complex coronary diseases than their younger counterparts. Hypertension, chronic kidney disease, COPD, and peripheral vascular disease were more common among patients ≥ 75 years, which would be understandable given the fact that these pathologies are associated with an advanced age. There were a higher number of active smokers and male patients in the younger group, possibly for the reason that more elderly patients had quit smoking, and women, in general, have a relative longer life expectancy than men.[@b15] It was also found that cardiogenic shock and severe arrhythmia at admission were more common among the elderly patients, indicating a graver impact of coronary heart disease on the elderly, in accordance with our findings of a greater incidence of multi-vessel disease, calcified lesions and chronic total occlusion among patients ≥ 75 years old. All of the above mentioned conditions increase the difficulty of PCI procedure and probability of adverse outcomes.[@b16] However, prior revascularization (PCI or CABG) was more prevalent in the younger group, partly for the reason that younger patients had a relatively higher incidence of prior myocardial infarction (9.2% *vs*. 5.2%, *P* = 0.07) and patients who experienced two episodes of myocardial infarction could seldom live a life longer than 75 years.

Despite the difference in clinical characteristics, the major problems associated with PCI in elderly patients ≥ 75 years old were high mortality and incidence of complications. Studies suggested that patient ≥ 75 years undergoing PCI had a higher incidence of procedure complications and worse outcomes, be they in-hospital, short-term or long-term ones.[@b3], [@b9] One of the most worrisome perioperative complications has been contrast-induced nephropathy, which was reported to occur in 2% to 25% of all patients receiving PCI treatment.[@b17] Although the incidence of contrast-induced nephropathy in our study was lower than results from a previous large cohort study of patients,[@b18] which reported an incidence of 9.4%, we still found that it was significantly higher among the elderly patients (3.8% *vs*. 0.5%, *P* = 0.01), which was correlated with a relatively higher level of serum creatinine, uric acid and urea nitrogen, and with chronic kidney disease that was seen more often among the elderly. Several factors including volume of contrast-medium \> 200 mL, anemia, eGFR \< 60 mL/min per 1.73^2^ were found related to contrast-induced nephropathy.[@b17],[@b19] Therefore, measures like evaluating kidney function, reducing the volume of contrast-medium, and alleviating anemia may be helpful. With pre-emptive hydration treatment, the incidence of contrast-induced nephropathy could be reduced.[@b20] Mortality of the elderly patients undergoing PCI varied considerably with different types of coronary heart diseases. The in-hospital and six-month mortality of patients with ACS was 4.5% and 8.4% respectively, among which ST-segment elevated myocardial infarction was the worst, with a six-month mortality rate of 15.9%, whereas among those with SA, the in-hospital mortality was 0% and so was six-month counterpart mortality. Our results correlated well with previous studies by Teplisky, *et al*.[@b21] and Sillano, *et al*.[@b22]

In our study, we identified cardiogenic shock and severe arrhythmia at admission, chronic kidney disease, and prior strokes as independent risk factors for six-month mortality among elderly patients undergoing PCI for coronary artery disease, partly in alignment with the result of a study done by Bauer, *et al*.[@b3] which regarded age, female gender, hemodynamic instability, STEMI, prior stroke, chronic renal failure, congestive heart failure, and diabetes mellitus as independent risk factors for in-hospital mortality among patients ≥ 75 years old undergoing PCI for acute coronary syndrome. One study reported that independent risk factors of in-hospital adverse events among elderly patients (\> 65 years) who underwent primary PCI included Killip \> 1, post-thrombolysis in myocardial infarction \< 3 and admission blood glucose levels.[@b23] Another study that surveyed over four million patients with acute myocardial infarction identified intra-aortic balloon pump use, acute renal failure, acute cerebrovascular disease, age ≥ 80 years, peripheral vascular disease, gastrointestinal bleeding, female gender, congestive heart failure, chronic lung disease, weekend admission and multi-vessel PCI as independent risk factors of in-hospital mortality among elderly patients who underwent PCI.[@b10] The difference of various risk factors for mortality among elderly patients in these studies may be attributable to ethnicity and selection criteria of patients. However, all these results indicated that renal deficiency (be it acute or chronic), hemodynamic instability, and complex coronary lesions are the main causes of adverse outcomes among elderly patients even with optimal reperfusion therapy for their coronary artery disease.

4.1. Limitations {#s4a}
----------------

Several limitations should be taken into consideration when the results of this study are interpreted. Relative small sample size may be the main limitation in our study, which might affect the results of logistic regression analysis of multiple risk factors and Kaplan-Meier survival analysis. Secondly, the time of follow-up is relative short, which may not uncover the long-term clinical characteristics and outcomes of elderly patients following PCI. Furthermore, the fact that the population is sourced from a single hospital and the patients are all ethnically Chinese, also are limitations of this study generalizability.

4.2. Conclusions {#s4b}
----------------

PCI has become safer and more effective in elderly patients ≥ 75 years old. This is possibly due to extensive use of drug-eluting stents and standardization of medical treatment adjunctive PCI procedure.[@b24] Age should not be a contraindication when patients are being considered for PCI treatment. Nevertheless, mortality and incidence of adverse outcomes are significantly higher in this special patients group, compared with the younger patient populations. Cardiogenic shock and severe arrhythmia at admission, chronic kidney disease, prior stroke were strongly related to in-hospital and short-term mortality outcomes among patients ≥ 75 years. These observations revealed the complexity of the multiple factors influencing PCI in elderly patients, which needs more researches to find effective measures to improve the survival and outcome after PCI procedure.
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